Search Results: 值得信賴的SPLK-1003 新版題庫上線和資格考試中的領先供應商和考試認證Splunk Splunk Enterprise Certified Admin 👄 到▛ www.newdumpspdf.com ▟搜索➽ SPLK-1003 🢪輕鬆取得免費下載最新SPLK-1003題庫

Meet with Christopher Kata during DIA 2021 Virtual Meeting on June 27 – July 1st

05/27/2021

Meet with Christopher Kata, Director of Sales & Marketing on June 27 – July 1st! Christopher Kata, Director of Sales & Marketing905 [email protected] When: June 27th – July 1st 2021Where: It’s Virtual!Registration: https://www.diaglobal.org/en/cart Recognizing and adapting to a new era of global change and uncertainty, DIA’s key tenets remain unchanged. Patients are our story, we…

Read More

Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection

11/24/2021

Excerpt from the Press Release: MADISON, Wis. and PHILADELPHIA, Nov. 18, 2021 /PRNewswire/ — Exact Sciences Corp. (NASDAQ: EXAS) today announced an agreement with Jefferson Health (Jefferson) to conduct research on a new blood-based, multi-cancer earlier detection (MCED) test. This unique effort will engage primary care and specialty providers, care coordinators, and patients from diverse populations across the Jefferson enterprise in research that aims…

Read More

How Ala Stanford Became a Champion for the Health of Black Philadelphians Amid COVID

08/12/2020

Excerpt from the Article: It was purely by chance that at the very moment Ala Stanford walked into a revival service at a Philly church last summer, a man fainted and was suddenly unable to move or speak. Frantic and afraid, the man’s wife, a friend of Stanford’s, asked the board-certified surgeon to ride in…

Read More

iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform

08/18/2022

CRISPR/Cas system for bacteria that are not E. coli or Streptococcus pyogenes Customized gene editing technology for unique modified-bacteriophages To validate efficacy of SARS-CoV-2 mimotopes loaded PHAGERUS® platform Excerpt from the Press Release: BOSTON and SEOUL, South Korea, Aug. 9, 2022 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) announced today that iNtRON has developed its unique CRISPR/Cas system customized for the genetic modification of certain bacteria…

Read More

Biological Dynamics launches ExoVita™ Pancreas and enrolls patients in ExoLuminate clinical trial

02/21/2023

Excerpt from the Press Release: AN DIEGO–(BUSINESS WIRE)–Biological Dynamics, Inc., a company commercializing its exosome-isolation ExoVerita™ platform for early disease surveillance and other applications, today announced completion of the analytical and clinical validation of its lab developed test (LDT), ExoVita™ Pancreas in the company’s CLIA certified and CAP accredited laboratory. Using blood-based exosome samples enriched…

Read More

Meet with Christopher Kata at “10th Annual SCOPE Summit 2019″at Booth 100 on February 18th – 21st 2019

01/23/2019

Meet with Christopher Kata, Director of Sales & Marketing on February 18th — 21st 2019 at the 10th Annual SCOPE Summit 2019 at Booth #100! Christopher Kata, Director of Sales & Marketing 905 999-1957 [email protected] When: February 18th — 21st 2019 Booth: #100 Where: Hyatt Regency Orlando, 9801 International Drive, Orlando, FL 32819 Registration: https://www.scopesummit.com    …

Read More

IncellDx’s Chronic COVID Treatment Center Partners with ARISE MD Integrative Medicine & Surgery to Evaluate Novel Therapeutic Approach to Chronic COVID

11/25/2021

Adam Miller, MD, to Serve as Lead Investigator for the First Randomized, Placebo Controlled Trial of CCR5 Antagonists and Statins for Chronic COVID Excerpt from the Press Release: SAN CARLOS, Calif.–(BUSINESS WIRE)–IncellDx’s Chronic COVID Treatment Center (CCTC) (www.covidlonghaulers.com) and ARISE™ MD Integrative Medicine & Surgery announced today a new partnership to evaluate CCR5 antagonists and…

Read More

Meet with Christopher Kata and the TrialStat team (booth # 1020), during the SCOPE Summit, February 11th – 14th, in Orlando!

01/18/2024

Meet with Christopher Kata, Director of Sales & Marketing February 11th – 14th, 2024 at the SCOPE Summit for Clinical Operations Executives in Orlando, Florida. Christopher and the TrialStat team are exhibiting in booth # 1020. Christopher Kata, Director of Sales & Marketing905 [email protected] Event: SCOPE – Summit for Clinical Operations Executives When: February 11th…

Read More

Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test

08/17/2022

Excerpt from the Press Release: EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) — Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today announced that Health Canada has granted Authorization under Interim Order for the emergency…

Read More

Meet with Christopher Kata and the TrialStat team (booth # 906), during the SCOPE Summit, February 6th – 9th, in Orlando!

01/19/2023

Meet with Christopher Kata, Director of Sales & Marketing February 6th – 9th, 2023 at the SCOPE Summit for Clinical Operations Executives in Orlando, Florida. Christopher and the TrialStat team are exhibiting in booth # 906. Christopher Kata, Director of Sales & Marketing905 [email protected] Event: SCOPE – Summit for Clinical Operations Executives When: February 6th…

Read More